Company Description
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies.
It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.
The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors.
It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office.
The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million.
It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity.
The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions.
The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
| Country | United States |
| Founded | 2004 |
| IPO Date | Oct 6, 2004 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 32 |
| CEO | Robert DeVeer |
Contact Details
Address: 1800 Avenue of the Stars, Suite 1400 Los Angeles, California 90067-4733 United States | |
| Phone | 310-201-4100 |
| Website | arescapitalcorp.com |
Stock Details
| Ticker Symbol | ARCC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001287750 |
| CUSIP Number | 04010L103 |
| ISIN Number | US04010L1035 |
| Employer ID | 33-1089684 |
Key Executives
| Name | Position |
|---|---|
| Robert Kipp DeVeer III | Chief Executive Officer and Director |
| Bennett Rosenthal | Co-Founder and Chairman Emeritus |
| Michael J. Arougheti | Executive Vice President and Director |
| James Miller | President |
| Scott C. Lem | Chief Financial Officer and Treasurer |
| Jana Markowicz | Chief Operating Officer |
| Won Jae Cho | Chief Accounting Officer |
| John W. Stilmar | Partner and Co-Head of Public Markets Investor Relations |
| Joshua M. Bloomstein J.D. | Vice President, General Counsel and Secretary |
| Lisa A. Morgan | Chief Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 24, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 10-K/A | [Amend] Annual report |
| Mar 10, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 10, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 10, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 20, 2025 | 40-APP/A | Filing |
| Feb 5, 2025 | 8-K | Current Report |
| Feb 5, 2025 | 424B2 | Prospectus |
| Feb 5, 2025 | 8-K | Current Report |
| Feb 5, 2025 | 10-K | Annual Report |